Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Salicylamide | HCID 5147 | — |
| Reactant | HCID 18760863 | HCID 18760863 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | HCID 18760865 | HCID 18760865 | 74.6% |
Reaction Steps
To a stirred solution of polyphosphonate ethyl ester (PPE) (3.46 g, 8.0 mmol) in chloroform (10 mL) was added salicylamide (548 mg, 4.0 mmol) followed by addition of a solution of (±)-Methyl 2-ethoxy-3-[4-[(2,2diethoxy)ethoxy]phenyl]propanoate (1.28 g, 4.4 mmol) obtained in preparation 2, in chloroform (10 mL) dropwise at 25-30° C. The reaction mixture was immersed in a preheated oil bath at 70° C. and refluxed 12 h. The reaction mixture was cooled to room temperature and CHCl3 was removed under reduced pressure. The resultant residue was neutralised (pH=7.0) with saturated aqueous NaHCO3 solution and extracted with ethyl acetate (3×20 mL). The combined organic extracts were washed with brine, dried over anhydrous Na2SO4 and concentrated. The crude compound was chromatographed on silica gel using a gradient of 5-25% of ethyl acetate in pet ether as eluent to afford the title compound (1.15 g, 72%) as a pale yellow liquid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06331627B1 |
|---|
| Source dataset | uspto-grants-2001_12 |
|---|
| ORD ID | ord-cc648f268bc3455d8698699f81c58d47 |
|---|
| Source note | uspto-grants-2001_12 |
|---|